We are live on ! Find out more
CAM

Cormorant Asset Management Portfolio holdings

AUM $1.99B
1-Year Est. Return 737.95%
This Fund
S&P 500
This Quarter Est. Return
+47.61%
1 Year Est. Return
+737.95%
3 Year Est. Return
+5,256.52%
5 Year Est. Return
+13,483.26%
10 Year Est. Return
+564,575.55%
AUM
$1.49B
AUM Growth
+$63.7M
Cap. Flow
-$72.5M
Cap. Flow %
-4.85%
Top 10 Hldgs %
49.88%
Holding
81
New
8
Increased
11
Reduced
24
Closed
8

Top Buys

Rank Stock Value
1
ETNB
89bio
ETNB
+$22.9M
2
AXSM icon
Axsome Therapeutics
AXSM
+$19.4M
3
PRME icon
Prime Medicine
PRME
+$13.3M
4
PCVX icon
Vaxcyte
PCVX
+$12.8M
5
BCAB icon
BioAtla
BCAB
+$12.4M

Top Sells

Rank Stock Value
1
GOSS icon
Gossamer Bio
GOSS
+$38.3M
2
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$27.9M
3
ACLX
Arcellx
ACLX
+$22.3M
4
ACET icon
Adicet Bio
ACET
+$12.5M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$11.3M

Sector Composition

Rank Sector Weight
1 Healthcare 99.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TYRA icon
76
Tyra Biosciences
TYRA
$1.58B
– –
-743,988
Closed -$6.54M
ISEE
77
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-500,000
Closed -$8.97M
IMV
78
DELISTED
IMV Inc. Common Shares
IMV
– –
-23,437
Closed -$122K
GLS
79
DELISTED
Gelesis Holdings, Inc.
GLS
– –
-626,107
Closed -$676K
AKUS
80
DELISTED
Akouos Inc
AKUS
– –
-394,500
Closed -$2.67M
BHVN
81
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-184,894
Closed -$27.9M
1 2 3
4

Similar funds

SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
C
Consulta London, United Kingdom $2.01B AUM 16.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return

Cormorant Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Cormorant Asset Management held 81 positions worth $1.49B, up 4.5% from $1.43B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Cormorant Asset Management withdrew a net $72.5M in Q4 2022, closing 8 positions and reducing 24 holdings. Its most notable exit was Gossamer Bio, an estimated $38.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier.

Against the trend, Cormorant Asset Management opened a new position in 89bio worth $32.5M.

  • Cormorant Asset Management's largest Q4 2022 buy was 89bio: 2,550,000 shares worth $32.5M.
  • Cormorant Asset Management added most to BioAtla in Q4 2022, an estimated $12.4M increase.
  • Cormorant Asset Management's biggest Q4 2022 reduction was Arcellx, cutting an estimated $22.3M.
  • Cormorant Asset Management fully exited Gossamer Bio in Q4 2022, selling an estimated $38.3M.
  • Cormorant Asset Management's ten largest holdings make up 50% of its $1.49B portfolio in Q4 2022.
  • Cormorant Asset Management opened 8 new positions and closed 8 in Q4 2022.
  • Cormorant Asset Management's portfolio value rose 4.5% quarter-over-quarter to $1.49B.

Based on Cormorant Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.